Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+137.0%/yr
Annual compound
5Y CAGR
+32.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.00B | +28.5% |
| 2024 | $781.37M | +97.0% |
| 2023 | $396.59M | +425.8% |
| 2022 | $75.42M | +13.3% |
| 2021 | $66.56M | -73.4% |
| 2020 | $250.65M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |